These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


328 related items for PubMed ID: 24797310

  • 1. Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.
    Fan C, Zheng W, Fu X, Li X, Wong YS, Chen T.
    Oncotarget; 2014 May 15; 5(9):2853-63. PubMed ID: 24797310
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo.
    Fan C, Zheng W, Fu X, Li X, Wong YS, Chen T.
    Cell Death Dis; 2014 Apr 24; 5(4):e1191. PubMed ID: 24763048
    [Abstract] [Full Text] [Related]

  • 3. Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathway.
    Fan C, Chen J, Wang Y, Wong YS, Zhang Y, Zheng W, Cao W, Chen T.
    Free Radic Biol Med; 2013 Dec 24; 65():305-316. PubMed ID: 23837948
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo.
    Yao S, Ye J, Yin M, Yu R.
    Cancer Lett; 2020 Jul 28; 483():87-97. PubMed ID: 32268165
    [Abstract] [Full Text] [Related]

  • 7. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
    Zhang X, Ma J, Song N, Guo Y, Hui L, Sang C.
    Pharmacology; 2020 Jul 28; 105(11-12):705-714. PubMed ID: 32062649
    [Abstract] [Full Text] [Related]

  • 8. Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo.
    Liu Y, Bi T, Dai W, Wang G, Qian L, Gao Q, Shen G.
    Tumour Biol; 2016 Jun 28; 37(6):7589-97. PubMed ID: 26687645
    [Abstract] [Full Text] [Related]

  • 9. (-)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Through the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways.
    Satonaka H, Ishida K, Takai M, Koide R, Shigemasa R, Ueyama J, Ishikawa T, Hayashi K, Goto H, Wakusawa S.
    Anticancer Res; 2017 Nov 28; 37(11):6071-6077. PubMed ID: 29061787
    [Abstract] [Full Text] [Related]

  • 10. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
    Choi J, Yip-Schneider M, Albertin F, Wiesenauer C, Wang Y, Schmidt CM.
    J Surg Res; 2008 Dec 28; 150(2):219-26. PubMed ID: 18468633
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
    Manov I, Pollak Y, Broneshter R, Iancu TC.
    FEBS J; 2011 Sep 28; 278(18):3494-507. PubMed ID: 21790999
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway.
    Gao C, Li X, Yu S, Liang L.
    J BUON; 2019 Sep 28; 24(5):1964-1969. PubMed ID: 31786862
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells.
    Chen L, Ye HL, Zhang G, Yao WM, Chen XZ, Zhang FC, Liang G.
    PLoS One; 2014 Sep 28; 9(1):e85771. PubMed ID: 24465696
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.